AVR 1.15% $17.99 anteris technologies ltd

Vax competition?, page-2

  1. 465 Posts.
    The results for the SP didn't do much for Genocea Biosciences: GNCA. I wouldn't be surprised if the market ignores the interim results for AHZ but its ok they'll just punt on spec resource sector based on hearsay.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.